Cargando…
Evaluation of prophylactic polyclonal anti‐D antibodies: Differences in Fc‐glycosylation in commercial products
Autores principales: | Mori, Filippo, Salvatore, Alfonso, Ascione, Ester, Di Marzo, Raffaele, Fox, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298374/ https://www.ncbi.nlm.nih.gov/pubmed/34699082 http://dx.doi.org/10.1111/vox.13213 |
Ejemplares similares
-
MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc N-Glycosylation
por: Sénard, Thomas, et al.
Publicado: (2020) -
Polyclonal activation of human B lymphocytes by Fc fragments. I. Characterization of the cellular requirements for Fc fragment-mediated polyclonal antibody secretion by human peripheral blood B lymphocytes
Publicado: (1981) -
Requirement of a Blocking Step in Affinity Purification of Polyclonal Antibodies
por: Hamzehlou, Sepideh, et al.
Publicado: (2015) -
Engineered Fc-glycosylation switch to eliminate antibody effector function
por: Zhou, Qun, et al.
Publicado: (2020) -
Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis
por: Lu, Lenette L, et al.
Publicado: (2020)